Events Partner Content Advancing the Next Generation of Microbiome-Based Therapeuti... Join the Microbiome Movement in Asia
Partner Content Partner Content 4 Reasons Why Asia is the Next Hub of Microbiome Innovation Microbiome R&D in Asia-Pacific
News Promethera looks to Asia with €10m investment Belgium-based liver disease specialists Promethera Biosciences have received a leg-up for the Asian market in the form of a €10 million investment from Japanese business conglomerate ITOCHU Corp
News Regeneron's three-monthly gMG drug Livsayis cleared by FDA Regeneron has joined the crowded gMG market with an siRNA-based therapy, Livsayis, that only needs to be dosed four times a year.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.